PPIG and neoplasm: The results summarized in this review form the basis to further predict the susceptibility of human cancers to ellipticine and suggest this alkaloid for treatment in combination with CYP gene transfer (CYP-gene-directed enzyme-prodrug therapy) [99,100], which has the potential to provide efficient activation of ellipticine in target tumor tissue, thereby increasing the anticancer potential of this prodrug.